𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers

✍ Scribed by Lorraine Dugoff; Howard S. Cuckle; John C. Hobbins; Fergal D. Malone; Michael A. Belfort; David A. Nyberg; Christine H. Comstock; George R. Saade; Keith A. Eddleman; Peer Dar; Sabrina D. Craigo; Ilan E. Timor-Tritsch; Steven R. Carr; Honor M. Wolfe; Mary E. D'Alton


Book ID
113433878
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
130 KB
Volume
199
Category
Article
ISSN
1097-6868

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Maternal serum prostate-specific antigen
✍ N. J. Wald; A. K. Hackshaw; E. P. Diamandis; D. N. Melegos πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 3 views

It has been suggested that high levels of maternal serum prostate-specific (PSA) may be associated with fetal Down syndrome. We retrieved stored blood samples from 102 singleton Down syndrome pregnancies at 8-14 weeks' gestation and 99 at 15-22 weeks' gestation, together with samples from five unaff

SCHWANGERSCHAFTSPROTEIN 1 (SP1) AS A MAT
✍ Q.-P. QIN; M. CHRISTIANSEN; T. H. NGUYEN; S. SØRENSEN; S. O. LARSEN; B. NØRGAARD πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 237 KB πŸ‘ 3 views

The potential of the maternal serum concentration of schwangerschaftsprotein 1 (MSSP1) as a marker for Down syndrome (DS) pregnancies was evaluated in the fifth to the 20th gestational week using 156 DS pregnancies and 546 unaffected control pregnancies. In DS pregnancies, the median of the multiple